New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

41

End of Pfizer trial paves way for Covid-19 vaccine in 2020

Final results from Pfizer Inc.’s Covid-19 vaccine trial showed the company’s shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days.

43

Analysis: Can first Covid-19 vaccines bring herd immunity? Experts have doubts

Governments and officials are voicing hopes that Covid-19 vaccines could bring “herd immunity”, with some calculating that immunizing just two-thirds of a population could halt the pandemic disease and help protect whole communities or nations.

44

Global daily coronavirus deaths cross record – Reuters tally

The number of reported global daily deaths from the coronavirus reached 10,816 on Nov. 17, according to a Reuters tally, the highest single-day death count as the virus’ global epicenter the United States entered winter.

47

EVERSANA and WorldQuant Predictive Form Partnership

EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, partnered with WorldQuant Predictive (WQP), a market leader in quantitative predictions and data-driven decisions through a cloud-based artificial intelligence (AI) platform, to improve the end result for patients.

48

Pfizer-BioNTech and Moderna’s Vaccines Lead the Covid-19 Race; How Do They Compare?

BioSpace takes a look at Moderna at the similarities between the two, and a few differencesPfizer-BioNTech and Moderna Covid-19 vaccines preliminary data readout of its COVID-19 vaccine suggested a 90% efficacy rate, the U.S. and western countries have the promise of two effective and reasonably safe vaccines. There are . Here’s a look.

49

BrainStorm’s ALS Drug Flops Phase III Study

A Phase III trial of NurOwn (MSC-NTF cells), BrainStorm Cell Therapeutics’ investigational therapy for amyotrophic lateral sclerosis, did not find a statistically significant difference between the product and placebo for improving scores on a revised ALS functional rating scale (ALSFRS-R) that measures the severity of the disease.